Hormonal Therapeutic Strategies for Prostate Cancer: Clinical Evidence and Practical Considerations

Hormonal Therapeutic Strategies for Prostate Cancer: Clinical Evidence and Practical Considerations Chair, Matthew R. Smith, MD, PhD, Neeraj Agarwal, MD, and Tanya Dorff, MD, discuss prostate cancer in this CME/MOC activity titled “Expanding Use of Hormonal Therapeutic Strategies in Prostate Cancer: Clinical Evidence and Practical Considerations for Individualized, Patient-Centered Care.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/PNF865. CME/MOC credit will be available until March 17, 2024.

Optimal Duration of Hormone Therapy For #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI
▶︎

Optimal Duration of Hormone Therapy For #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

What is the ideal duration of hormone therapy for the treatment of prostate cancer?
▶︎

What is the ideal duration of hormone therapy for the treatment of prostate cancer?

JCO at ASCO 2026: Intravesical Recombinant BCG with Chemo-Immunotherapy in MIBC
▶︎

JCO at ASCO 2026: Intravesical Recombinant BCG with Chemo-Immunotherapy in MIBC

Novel Treatment Strategies and Latest Evidence for Metastatic Castration-Sensitive Prostate Cancer
▶︎

Novel Treatment Strategies and Latest Evidence for Metastatic Castration-Sensitive Prostate Cancer

Hormonal Therapy for Prostate Cancer
▶︎

Hormonal Therapy for Prostate Cancer

JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma
▶︎

JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma

New Advances in Prostate Cancer in 2025
▶︎

New Advances in Prostate Cancer in 2025

Strategies for Handling and Managing Prostate Cancer Recurrence: Expert Tips
▶︎

Strategies for Handling and Managing Prostate Cancer Recurrence: Expert Tips

Short Term vs. Long Term Of Hormone Therapy For #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI
▶︎

Short Term vs. Long Term Of Hormone Therapy For #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

Prostate Cancer in 2024: Recent Updates and Treatment Advances
▶︎

Prostate Cancer in 2024: Recent Updates and Treatment Advances

Surgery or Radiotherapy for Prostate Cancer? Here's What the Evidence Shows
▶︎

Surgery or Radiotherapy for Prostate Cancer? Here's What the Evidence Shows

What every patient should know about ADT (hormone) therapy
▶︎

What every patient should know about ADT (hormone) therapy

Gleason 3+4 Prostate Cancer
▶︎

Gleason 3+4 Prostate Cancer

Radiation & Side Effects For Prostate Cancer | Mack Roach III, MD & Q+A with Mark Moyad, MD #PCRI
▶︎

Radiation & Side Effects For Prostate Cancer | Mack Roach III, MD & Q+A with Mark Moyad, MD #PCRI

ADT for Prostate Cancer: Agonists vs Antagonists
▶︎

ADT for Prostate Cancer: Agonists vs Antagonists

Exercise for Prostate Cancer Patients
▶︎

Exercise for Prostate Cancer Patients

Changing the Treatment Story With Hormonal Therapy in Prostate Cancer
▶︎

Changing the Treatment Story With Hormonal Therapy in Prostate Cancer

All About Prostate Cancer: The Most Effective Treatments and How to Get Them
▶︎

All About Prostate Cancer: The Most Effective Treatments and How to Get Them

What they don't tell you about Androgen Deprivation Therapy (ADT, hormone therapy)
▶︎

What they don't tell you about Androgen Deprivation Therapy (ADT, hormone therapy)

PROSTATE CANCER:  What's my prognosis? | Grade, Stage, PSA, Gleason score and novel genomic assays
▶︎

PROSTATE CANCER: What's my prognosis? | Grade, Stage, PSA, Gleason score and novel genomic assays